Events › B2B Event
B2B Event
5th edition
The 5th Targeted Radiopharmaceuticals Summit US 2026 is a premier B2B conference focused on radioligand therapy (RLT). It connects 260+ industry professionals for discussions on discovery, development, translational science, and manufacturing of Targeted Radiopharmaceuticals.
Exhibitor mix: Sponsors, technology partners, and service providers (CRO/CMO) in targeted radiopharmaceuticals.
Filter this event to your ICP.
Hundreds of exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Organizer
Hanson WadePE-backed · London, United Kingdom · Founded 2008
Hanson Wade is a global conference organizer and market intelligence provider focused primarily on the life sciences and biopharma sectors.
Why people attend
To find partners for RLT development, isotope sourcing, and CMC services, as well as to hear case studies from leading biopharma companies.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
More events in United States
Frequently asked questions